321
Views
1
CrossRef citations to date
0
Altmetric
Articles

Protein-liposome interactions: the impact of surface charge and fluidisation effect on protein binding

, ORCID Icon & ORCID Icon
Pages 77-88 | Received 27 Dec 2021, Accepted 18 Apr 2022, Published online: 22 Jun 2022

References

  • Abe, K., et al., 2015. Effects of the PEG molecular weight of a PEG-lipid and cholesterol on PEG chain flexibility on liposome surfaces. Colloids and surfaces A: physicochemical and engineering aspects, 474, 63–70.
  • Aldosari B.N., Alfagih I.M., and Almurshedi A.S., 2021. Lipid nanoparticles as delivery systems for RNA-based vaccines. Pharmaceutics, 13 (26), 206.
  • Aloi, E., et al., 2020. Binding of warfarin differently affects the thermal behavior and chain packing of anionic, zwitterionic and cationic lipid membranes. Archives of biochemistry and biophysics, 694, 108599–10.
  • Barui, A.K., et al., 2020. Cancer-targeted nanomedicine: overcoming the barrier of the protein corona. Advanced therapeutics, 3 (1), 1900116–1900124.
  • Bedu-Addo, F.K., and Huang, L., 1995. Interaction of PEG-phospholipid conjugates with phospholipid: implications in liposomal drug delivery. Advanced drug delivery reviews, 16 (2–3), 235–247.
  • Bedu-Addo, F.K., et al., 1996. Effects of polyethyleneglycol chain length and phospholipid acyl chain composition on the interaction of polyethyleneglycol-phospholipid conjugates with phospholipid: implications in liposomal drug delivery. Pharmaceutical research, 13 (5), 710–717.
  • Belsito, S., Bartucci, R., and Sportelli, L., 1998. Sterically stabilized liposomes of DPPC/DPPE-PEG:2000. A spin label ESR and spectrophotometric study. Biophysical chemistry, 75 (1), 33–43.
  • Beltrán-Gracia, Ε., et al., 2019. Nanomedicine review: clinical developments in liposomal applications. Cancer nanotechnology, 10 (1), 1–40.
  • Benne, N., et al., 2018. Anionic 1,2-distearoyl-sn-glycero-3-phosphoglycerol (DSPG) liposomes induce antigen-specific regulatory T cells and prevent atherosclerosis in mice. Journal of controlled release, 291, 135–146.
  • Binder, W.H., Barragan, V., and Menger, F.M., 2003. Domains and rafts in lipid membranes. Angewandte chemie, 42 (47), 5802–5827.
  • Bonte, F., and Juliano, R.L., 1986. Interactions of liposomes with serum proteins. Chemistry and physics of lipids, 40 (2–4), 359–372.
  • Bulbake, U., et al., 2017. Liposomal formulations in clinical use: an updated review. Pharmaceutics, 9 (4), 12–33.
  • Capriotti, A.L., et al., 2012. Do plasma proteins distinguish between liposomes of varying charge density? Journal of proteomics, 75 (6), 1924–1932.
  • Caracciolo, G., et al., 2013. Effect of DOPE and cholesterol on the protein adsorption onto lipid nanoparticles. Journal of nanoparticle research, 15 (3), 1491–1498.
  • Caracciolo, G., et al., 2015. Lipid composition: a “key factor” for the rational manipulation of the liposome-protein corona by liposome design. RSC advances, 5 (8), 5967–5975.
  • Chakraborty, D., Ethiraj, K.R., and Mukherjee, A., 2020. Understanding the relevance of protein corona in nanoparticle-based therapeutics and diagnostics. RSC advances, 10 (45), 27161–27172.
  • Chiu, M.H., and Prenner, E.J., 2011. Differential scanning calorimetry: an invaluable tool for a detailed thermodynamic characterization of macromolecules and their interactions. Journal of pharmacy & bioallied sciences, 3 (1), 39–59.
  • Demetzos, C., 2008. Differential scanning calorimetry (DSC): a tool to study the thermal behavior of lipid bilayers and liposomal stability. Journal of liposome research, 18 (3), 159–173.
  • Demetzos, C., 2014. Pharmaceutical nanotechnology basics and applications. Athens: Parisianou.
  • Digiacomo, L., et al., 2020. Impact of the protein corona on nanomaterial immune response and targeting ability. WIREs nanomedicine and nanobiotechnology, 12 (4), 1–15.
  • Dos Santos, N., et al., 2007. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding. Biochimica et biophysica acta, 1768 (6), 1367–1377.
  • Du, H., Chandaroy, P., and Hui, S.W., 1997. Grafted poly- ethylene glycol on lipid surfaces inhibits protein adsorption and cell adhesion. Biochimica et biophysica acta, 1326 (2), 236–248.
  • Gaspar, R., Coelho, F., and Silva, B.F.B., 2020. Lipid-nucleic acid complexes: physicochemical aspects and prospects for cancer treatment. Molecules, 25 (21), 5006–5039.
  • Giulimondi, F., et al., 2019. Interplay of protein corona and immune cells controls blood residency of liposomes. Nature communications, 10 (1), 3611–3686.
  • Hatziantoniou, S., and Demetzos, C., 2008. Lipids of membranes: chemistry, biological role, and applications as drug carriers. Studies in natural products chemistry, 34, 173–202.
  • Heuts, J., et al., 2021. Cationic nanoparticle-based cancer vaccines. Pharmaceutics, 13 (5), 519–596.
  • Hou, X., et al., 2021. Lipid nanoparticles for mRNA delivery. Nature reviews. materials, 6 (12), 1078–1094.
  • Hristova, K., Kenworthy, A., and McIntosh, T.J., 1995. Effect of bilayer composition on the phase behavior of liposomal suspensions containing poly(ethy1ene glycol)-lipids. Macromolecules, 28 (23), 7693–7699.
  • Huang, C-h., and Li, S., 1999. Calorimetric and molecular mechanics studies of the thermotropic phase behavior of membrane phospholipids. Biochimica et biophysica acta, 1422 (3), 273–307.
  • Immordino, M.L., Dosio, F., and Cattel, L., 2006. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. International journal of nanomedicine, 1 (3), 297–315.
  • Kenworthy, A.K., et al., 1995. Range and magnitude of the steric pressure between bilayers containing phospholipids with covalently attached poly(ethylene glycol). Biophysical journal, 68 (5), 1921–1936.
  • Klein, M.E., et al., 2021. Towards the development of long circulating phosphatidylserine (PS)- and phosphatidylglycerol (PG)-enriched anti-inflammatory liposomes: is pegylation effective? Pharmaceutics, 13 (2), 216–282.
  • Koynova, R., and Caffrey, M., 1998. Phases and phase transitions of the phosphatidylcholines. Biochimica et biophysica acta, 1376 (1), 91–145.
  • Kristensen, K., et al., 2019. The hard protein corona of stealth liposomes is sparse. Journal of controlled release, 307, 1–15.
  • Lee, A.G., 1977. Lipid phase transitions and phase diagrams. I. Lipid phase transitions. Biochimica et biophysica acta, 472 (2), 237–281.
  • Lee, H., and Larson, R.G., 2016. Adsorption of plasma proteins onto PEGylated lipid bilayers: the effect of PEG size and grafting density. Biomacromolecules, 17 (5), 1757–1765.
  • Lewis, R.N.A.H., Mak, N., and McElhaney, N.R., 1987. A differential scanning calorimetric study of the thermotropic phase behavior of model membranes composed of phosphatidylcholines containing linear saturated fatty acyl chains. Biochemistry, 26 (19), 6118–6126.
  • Li, J., et al., 2015. A review on phospholipids and their main applications in drug delivery systems. Asian Journal of pharmaceutical sciences, 10 (2), 81–98.
  • Lian, T., and Ho, R.J.Y., 2001. Minireview: trends and developments in liposome drug delivery systems. Journal of pharmaceutical sciences, 90 (6), 667–680.
  • Lin, Q., et al., 2014. Lipid-based nanoparticles in the systemic delivery of siRNA. Nanomedicine, 9 (1), 105–120.
  • Liu, C., et al., 2020. Barriers and strategies of cationic liposomes for cancer gene therapy. Molecular therapy. Methods & clinical development, 18, 751–764.
  • Lynch, I., et al., 2007. The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Advances in colloid and interface science, 134–135, 167–174.
  • Marzban, E., et al., 2015. Optimizing the therapeutic efficacy of cisplatin PEGylated liposomes via incorporation of different DPPG ratios: in vitro and in vivo studies. Colloids and surfaces. B, biointerfaces, 136, 885–891.
  • Matsingou, C., and Demetzos, C., 2007. Effect of the nature of the 3beta-substitution in manoyl oxides on the thermotropic behavior of DPPC lipid bilayer and on DPPC liposomes. Journal of liposome research, 17 (2), 89–105.
  • Montesano, G., et al., 2001. Lipid membrane expansion and micelle formation by polymer-grafted lipids: scaling with polymer length studied by spin-label electron spin resonance. Biophysical journal, 80 (3), 1372–1383.
  • Montizaan, D., et al., 2020. Comparison of the uptake mechanisms of zwitterionic and negatively charged liposomes by HeLa cells. Nanomedicine: nanotechnology, biology, and medicine, 30, 102300–10.
  • Onishchenko, N., Tretiakova, D., and Vodovozova, E., 2021. Spotlight on the protein corona of liposomes. Acta biomaterialia,134:57–78.
  • Papageorgiou, F., et al., 2019. Physicochemical study of the protein–liposome interactions: influence of liposome composition and concentration on protein binding. Journal of liposome research, 29 (4), 313–321.
  • Patil, S.D., Rhodes, D.G., and Burgess, D.J., 2005. DNA-based therapeutics and DNA delivery systems: a comprehensive review. The AAPS journal, 7 (1), E61–E77.
  • Perrie, Y., et al., 2016. Designing liposomal adjuvants for the next generation of vaccines. Advanced drug delivery reviews, 99 (Pt A), 85–96.
  • Pippa, N., Pispas, S., and Demetzos, C., 2012. The delineation of the morphology of charged liposomal vectors via a fractal analysis in aqueous and biological media: physicochemical and self-assembly studies. International journal of pharmaceutics, 437 (1–2), 264–274.
  • Pippa, N., Pispas, S., and Demetzos, C., 2016. Physico-chemical characterization and basic research principles of advanced drug delivery nanosystems. Intelligent nanomaterials. Chapter 5, Advanced Materials Book series. Wiley; 107–126.
  • Pippa, N., et al., 2013. The shape/morphology balance: a study of stealth liposomes via fractal analysis and drug encapsulation. Pharmaceutical research, 30 (9), 2385–2395.
  • Sabin, J., et al., 2006. Size and stability of liposomes: a possible role of hydration and osmotic forces. The European physical journal. E, soft matter, 20 (4), 401–408.
  • Semple, S.C., Chonn, Α., and Cullis, P.R., 1998. Interactions of liposomes and lipid-based carrier systems with blood proteins: relation to clearance behaviour in vivo. Advanced drug delivery reviews, 32 (1–2), 3–17.
  • Soema, P.C., et al., 2015. Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach. European journal of pharmaceutics and biopharmaceutics, 94, 427–435.
  • Tardi, P., Leon Wan, C.P., and Maye, L., 2016. Passive and semi-active targeting of bone marrow and leukemia cells using anionic low cholesterol liposomes. Journal of drug targeting, 24 (9), 797–804.
  • Vincent, M.P., et al., 2021. Surface chemistry-mediated modulation of adsorbed albumin folding state specifies nanocarrier clearance by distinct macrophage subsets. Nature communications, 12 (1), 618–648.
  • Wang, T., Upponi, J.R., and Torchilin, V.P., 2012. Design of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategies. International journal of pharmaceutics, 427 (1), 3–20.
  • Watson, D.S., Endsley, A.N., and Huang, L., 2012. Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens. Vaccine, 30 (13), 2256–2272.
  • Wolfram, J., et al., 2014. Shrinkage of pegylated and non-pegylated liposomes in serum. Colloids and surfaces. B, biointerfaces, 114, 294–300.
  • Wolfram, J., et al., 2014. The nano-plasma interface: implications of the protein corona. Colloids and surfaces. B, biointerfaces, 124, 17–24.
  • Xia, Y., Tian, J., and Chen, X., 2016. Effect of surface properties on liposomal siRNA delivery. Biomaterials, 79, 56–68.
  • Yokouchi, Y., et al., 2001. Effect of adsorption of bovine serum albumin on liposomal membrane characteristics. Colloids and surfaces. B, biointerfaces, 20 (2), 95–103.
  • Zhang, Y., et al., 2021. Layer-by-layer coated nanoliposomes for oral delivery of insulin. Nanoscale, 13 (2), 776–789.
  • Zhao, L., and Feng, S., 2004. Effects of lipid chain length on molecular interactions between paclitaxel and phospholipid within model biomembranes. Journal of colloid and interface science, 274 (1), 55–68.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.